Cargando…

The Acceptability and Effectiveness of Web-Based Developmental Surveillance Programs: Rapid Review

BACKGROUND: Web-based developmental surveillance programs may be an innovative solution to improving the early detection of childhood developmental difficulties, especially within disadvantaged populations. OBJECTIVE: This review aimed to identify the acceptability and effectiveness of web-based dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Jess, Kohlhoff, Jane, Onobrakpor, Se-Inyenede, Woolfenden, Sue, Smith, Rebecca, Knebel, Constanze, Eapen, Valsamma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206511/
https://www.ncbi.nlm.nih.gov/pubmed/32324149
http://dx.doi.org/10.2196/16085
Descripción
Sumario:BACKGROUND: Web-based developmental surveillance programs may be an innovative solution to improving the early detection of childhood developmental difficulties, especially within disadvantaged populations. OBJECTIVE: This review aimed to identify the acceptability and effectiveness of web-based developmental surveillance programs for children aged 0 to 6 years. METHODS: A total of 6 databases and gray literature were searched using a Preferred Reporting Items for Systematic Reviews and Meta-Analyses–informed protocol. Data extraction included variables related to health equity. RESULTS: In total, 20 studies were identified. Most papers implemented web-based versions of the Modified Checklist for Autism in Toddlers, Revised with Follow-Up screener for autism spectrum disorder or Parent Evaluation of Developmental Status screeners for broad developmental delay. Caregivers and practitioners indicated a preference for web-based screeners, primarily for user-friendliness, improved follow-up accuracy, time, and training efficiencies. CONCLUSIONS: Although evidence is limited as to the necessity of web- versus face-to-face–based developmental screening, there are clear efficiencies in its use. TRIAL REGISTRATION: PROSPERO CRD42019127894; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=127894